Literature DB >> 19352781

Identification of patients at risk for development of tertiary peritonitis on a surgical intensive care unit.

Ansgar M Chromik1, Andreas Meiser, Janine Hölling, Dominique Sülberg, Adrien Daigeler, Kirsten Meurer, Heike Vogelsang, Matthias H Seelig, Waldemar Uhl.   

Abstract

BACKGROUND: Tertiary peritonitis (TP) is defined as a severe recurrent or persistent intra-abdominal infection after adequate surgical source control of secondary peritonitis (SP). The aim of this study was to analyze the characteristics of patients with SP who will further develop TP in order to define early diagnostic markers for TP. STUDY
DESIGN: Over a 1-year period, all patients on the surgical intensive care unit (ICU) with SP were prospectively assessed for the development of TP applying the definition of the ICU consensus conference. The Mannheim Peritonitis Index (MPI), C-reactive protein (CRP) and Simplified Acute Physiology Score II (SAPS II) were assessed at the initial operation (IO) that was diagnostic for SP and in the postoperative period.
RESULTS: Among 69 patients with SP, 15 patients further developed TP, whereas 54 patients did not develop TP. Compared to SP, patients with transition to TP had significantly higher MPI at IO (28.6 vs. 19.8; p < 0.001), relaparotomy rate (2.00 vs. 0.11; p < 0.001), mortality (60% vs. 9%; p < 0.001), duration of ICU stay (14 vs. 4 days; p < 0.005), as well as SAPS II (45.1 vs. 28.4; p < 0.005) and CRP (265 mg/dL vs. 217 mg/dL; p < 0.05) on the second postoperative day after IO.
CONCLUSIONS: The MPI at IO as well as CRP and SAPS II at the second postoperative day helps to identify patients at risk for tertiary peritonitis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19352781     DOI: 10.1007/s11605-009-0882-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  22 in total

1.  Surgical management of severe secondary peritonitis.

Authors:  T Koperna
Journal:  Br J Surg       Date:  2000-03       Impact factor: 6.939

2.  SIRS, MODS and tertiary peritonitis.

Authors:  P H Reemst; H van Goor; R J Goris
Journal:  Eur J Surg Suppl       Date:  1996

3.  Procalcitonin in early detection of postoperative complications.

Authors:  H B Reith; U Mittelkötter; E S Debus; C Küssner; A Thiede
Journal:  Dig Surg       Date:  1998       Impact factor: 2.588

4.  Prediction of outcome using the Mannheim peritonitis index in 2003 patients. Peritonitis Study Group.

Authors:  A Billing; D Fröhlich; F W Schildberg
Journal:  Br J Surg       Date:  1994-02       Impact factor: 6.939

5.  Infectiological diagnostic problems in tertiary peritonitis.

Authors:  G Weiss; F Meyer; H Lippert
Journal:  Langenbecks Arch Surg       Date:  2006-08-15       Impact factor: 3.445

6.  Tertiary peritonitis (recurrent diffuse or localized disease) is not an independent predictor of mortality in surgical patients with intraabdominal infection.

Authors:  H L Evans; D P Raymond; S J Pelletier; T D Crabtree; T L Pruett; R G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2001       Impact factor: 2.150

7.  Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis.

Authors:  A A Dahaba; B Hagara; A Fall; P H Rehak; W F List; H Metzler
Journal:  Br J Anaesth       Date:  2006-07-18       Impact factor: 9.166

8.  Postoperative plasma concentrations of procalcitonin after different types of surgery.

Authors:  M Meisner; K Tschaikowsky; A Hutzler; C Schick; J Schüttler
Journal:  Intensive Care Med       Date:  1998-07       Impact factor: 17.440

9.  Age, microbiology and prognostic scores help to differentiate between secondary and tertiary peritonitis.

Authors:  Peter Panhofer; Barbara Izay; Markus Riedl; Veronika Ferenc; Martin Ploder; Raimund Jakesz; Peter Götzinger
Journal:  Langenbecks Arch Surg       Date:  2008-03-15       Impact factor: 3.445

10.  ["Simplified Acute Physiology Score" (SAPS II) ina the assessment of severity of illness in surgical intensive care patients].

Authors:  A Agha; T Bein; D Fröhlich; S Höfler; D Krenz; K W Jauch
Journal:  Chirurg       Date:  2002-05       Impact factor: 0.955

View more
  11 in total

1.  Prognostic factors of the mortality of postoperative intraabdominal infections.

Authors:  N Torer; K Yorganci; D Elker; I Sayek
Journal:  Infection       Date:  2010-08       Impact factor: 3.553

Review 2.  Searching for predictors of surgical complications in critically ill surgery patients in the intensive care unit: a review.

Authors:  Zainna C Meyer; Jennifer M J Schreinemakers; Ruud A L de Waal; Lijckle van der Laan
Journal:  Surg Today       Date:  2015-04-10       Impact factor: 2.549

3.  The intestinal environment of surgical injury transforms Pseudomonas aeruginosa into a discrete hypervirulent morphotype capable of causing lethal peritonitis.

Authors:  Trissa Babrowski; Kathleen Romanowski; David Fink; Moses Kim; Vissagan Gopalakrishnan; Olga Zaborina; John C Alverdy
Journal:  Surgery       Date:  2012-08-03       Impact factor: 3.982

4.  Essentials for selecting antimicrobial therapy for intra-abdominal infections.

Authors:  Stijn Blot; Jan J De Waele; Dirk Vogelaers
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

5.  Antimicrobial treatment of "complicated" intra-abdominal infections and the new IDSA guidelines ? a commentary and an alternative European approach according to clinical definitions.

Authors:  Christian Eckmann; M Dryden; P Montravers; R Kozlov; G Sganga
Journal:  Eur J Med Res       Date:  2011-03-28       Impact factor: 2.175

Review 6.  Treatment of complicated intra-abdominal infections in the era of multi-drug resistant bacteria.

Authors:  T Herzog; A M Chromik; Waldemar Uhl
Journal:  Eur J Med Res       Date:  2010-11-30       Impact factor: 2.175

7.  Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis.

Authors:  Philippe Montravers; Guillaume Dufour; Jean Guglielminotti; Mathieu Desmard; Claudette Muller; Hamda Houissa; Nicolas Allou; Jean-Pierre Marmuse; Pascal Augustin
Journal:  Crit Care       Date:  2015-03-02       Impact factor: 9.097

Review 8.  Tertiary peritonitis: A disease that should not be ignored.

Authors:  Hanna Santos Marques; Glauber Rocha Lima Araújo; Filipe Antônio França da Silva; Breno Bittencourt de Brito; Paulo Victor Dias Versiani; Jaqueline Silva Caires; Thiago de Carvalho Milet; Fabrício Freire de Melo
Journal:  World J Clin Cases       Date:  2021-04-06       Impact factor: 1.337

9.  Application of serum exosomal hypoxia-inducible factor-1 alpha (HIF-1α) as potential circulating biomarker for bacterial peritonitis.

Authors:  Xiao-Yi Chen; Qian-Long Wang; Wei-Xue Huang; Long-Wei Li; Lan-Cong Liu; Yi Yang; You-Jiao Wu; Shan-Shan Song; Hao Ma; Hua Zhou; Pei Luo
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

Review 10.  Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).

Authors:  Massimo Sartelli; Dieter G Weber; Etienne Ruppé; Matteo Bassetti; Brian J Wright; Luca Ansaloni; Fausto Catena; Federico Coccolini; Fikri M Abu-Zidan; Raul Coimbra; Ernest E Moore; Frederick A Moore; Ronald V Maier; Jan J De Waele; Andrew W Kirkpatrick; Ewen A Griffiths; Christian Eckmann; Adrian J Brink; John E Mazuski; Addison K May; Rob G Sawyer; Dominik Mertz; Philippe Montravers; Anand Kumar; Jason A Roberts; Jean-Louis Vincent; Richard R Watkins; Warren Lowman; Brad Spellberg; Iain J Abbott; Abdulrashid Kayode Adesunkanmi; Sara Al-Dahir; Majdi N Al-Hasan; Ferdinando Agresta; Asma A Althani; Shamshul Ansari; Rashid Ansumana; Goran Augustin; Miklosh Bala; Zsolt J Balogh; Oussama Baraket; Aneel Bhangu; Marcelo A Beltrán; Michael Bernhard; Walter L Biffl; Marja A Boermeester; Stephen M Brecher; Jill R Cherry-Bukowiec; Otmar R Buyne; Miguel A Cainzos; Kelly A Cairns; Adrian Camacho-Ortiz; Sujith J Chandy; Asri Che Jusoh; Alain Chichom-Mefire; Caroline Colijn; Francesco Corcione; Yunfeng Cui; Daniel Curcio; Samir Delibegovic; Zaza Demetrashvili; Belinda De Simone; Sameer Dhingra; José J Diaz; Isidoro Di Carlo; Angel Dillip; Salomone Di Saverio; Michael P Doyle; Gereltuya Dorj; Agron Dogjani; Hervé Dupont; Soumitra R Eachempati; Mushira Abdulaziz Enani; Valery N Egiev; Mutasim M Elmangory; Paula Ferrada; Joseph R Fitchett; Gustavo P Fraga; Nathalie Guessennd; Helen Giamarellou; Wagih Ghnnam; George Gkiokas; Staphanie R Goldberg; Carlos Augusto Gomes; Harumi Gomi; Manuel Guzmán-Blanco; Mainul Haque; Sonja Hansen; Andreas Hecker; Wolfgang R Heizmann; Torsten Herzog; Adrien Montcho Hodonou; Suk-Kyung Hong; Reinhold Kafka-Ritsch; Lewis J Kaplan; Garima Kapoor; Aleksandar Karamarkovic; Martin G Kees; Jakub Kenig; Ronald Kiguba; Peter K Kim; Yoram Kluger; Vladimir Khokha; Kaoru Koike; Kenneth Y Y Kok; Victory Kong; Matthew C Knox; Kenji Inaba; Arda Isik; Katia Iskandar; Rao R Ivatury; Maurizio Labbate; Francesco M Labricciosa; Pierre-François Laterre; Rifat Latifi; Jae Gil Lee; Young Ran Lee; Marc Leone; Ari Leppaniemi; Yousheng Li; Stephen Y Liang; Tonny Loho; Marc Maegele; Sydney Malama; Hany E Marei; Ignacio Martin-Loeches; Sanjay Marwah; Amos Massele; Michael McFarlane; Renato Bessa Melo; Ionut Negoi; David P Nicolau; Carl Erik Nord; Richard Ofori-Asenso; AbdelKarim H Omari; Carlos A Ordonez; Mouaqit Ouadii; Gerson Alves Pereira Júnior; Diego Piazza; Guntars Pupelis; Timothy Miles Rawson; Miran Rems; Sandro Rizoli; Claudio Rocha; Boris Sakakushev; Miguel Sanchez-Garcia; Norio Sato; Helmut A Segovia Lohse; Gabriele Sganga; Boonying Siribumrungwong; Vishal G Shelat; Kjetil Soreide; Rodolfo Soto; Peep Talving; Jonathan V Tilsed; Jean-Francois Timsit; Gabriel Trueba; Ngo Tat Trung; Jan Ulrych; Harry van Goor; Andras Vereczkei; Ravinder S Vohra; Imtiaz Wani; Waldemar Uhl; Yonghong Xiao; Kuo-Ching Yuan; Sanoop K Zachariah; Jean-Ralph Zahar; Tanya L Zakrison; Antonio Corcione; Rita M Melotti; Claudio Viscoli; Perluigi Viale
Journal:  World J Emerg Surg       Date:  2016-07-15       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.